FOLD R&D Expenses
Amicus Therapeutics Inc · R&D Expenses
FOLD R&D Expenses
Latest reported$135.84Mperiod ending
FOLD TTM R&D Expenses ($0.00 → $135.84M)
TTM R&D Expenses
High-resolution chart · PNG
FOLD r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 135,843,000 | |
| 142,292,000 | |
| 145,037,000 | |
| 108,872,000 | |
| 109,362,000 | |
| 114,201,000 | |
| 128,745,000 | |
| 139,211,000 | |
| 152,381,000 | |
| 181,223,000 | |
| 193,489,000 | |
| 236,659,000 | |
| 276,677,000 | |
| 298,402,000 | |
| 304,765,000 | |
| 289,449,000 | |
| 272,049,000 | |
| 265,746,000 | |
| 276,832,000 | |
| 283,440,000 | |
| 308,443,000 | |
| 321,062,000 | |
| 309,535,000 | |
| 310,905,000 | |
| 286,378,000 | |
| 251,683,000 | |
| 331,018,000 | |
| 294,697,000 | |
| 270,902,000 | |
| 259,493,000 | |
| 161,907,000 | |
| 159,232,000 | |
| 149,310,000 | |
| 134,132,000 | |
| 125,948,000 | |
| 112,244,000 | |
| 104,793,000 | |
| 96,788,000 | |
| 85,302,000 | |
| 84,255,000 | |
| 76,943,000 | |
| 69,923,000 | |
| 61,001,000 | |
| 53,745,000 | |
| 47,624,000 | |
| 41,139,000 | |
| 39,200,000 | |
| 39,947,000 | |
| 41,944,000 | |
| 43,871,000 | |
| 45,260,000 | |
| 48,258,000 | |
| 50,273,000 | |
| 53,627,000 | |
| 55,839,000 | |
| 53,734,000 | |
| 50,855,000 | |
| 49,608,000 | |
| 44,759,000 | |
| 41,278,000 | |
| 39,042,000 | |
| 36,015,000 | |
| 39,762,000 | |
| 45,095,000 | |
| 48,081,000 | |
| 51,729,000 | |
| 47,320,000 | |
| 42,698,000 | |
| 37,764,000 | |
| 33,659,000 | |
| 32,996,000 | |
| 30,931,000 | |
| 31,075,000 | |
| 21,405,000 | |
| 13,868,000 | |
| 7,085,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |